Info about the company:
Bussines discription:
Sutura is a medical device company which develops innovative, minimally invasive vascular suturing devices to suture vascular structures during open surgery and catheter-based procedures.
The company has four wholly owned subsidiaries namely, Technology Visions, Inc., Sutura BV, Sutura SARL, and Sutura GmbH which develop and provide vascular suturing devices.
The company operates through a single reportable business segment, namely, the design and development of suture devices.
The company’s SuperStitch line of products is used in cardiovascular and vascular procedures that require a puncture or incision to the artery. These products are designed for use with or without an access device (e.g., trocar, sheath, or cannula) depending on the endoscopic technique, for use during minimally invasive surgical procedures, fluoroscopically-guided procedures, or in an open setting. Currently, the products offered include F5 Superstitch, F8 and F6 Superstitch, Superstitch Guidewire, F12 and F18 Superstitch, Superstitch ASD and Superstitch PFO.
Further, Sutura currently manufactures, assembles, tests and packages its SuperStitch products at its facility in Fountain Valley, California. This manufacturing facility is registered with the FDA-QSR (Food and Drug Administration — Quality Systems Regulations) and an ISO (International Standards Organization) certified company. Sales offices of the company are leased in Amsterdam, the Netherlands and La Gaude, France to support sales and marketing efforts in Europe.
Sutura’s products are marketed to physicians for open surgical intervention and fluoroscopically guided procedures. The company is selling its products in the European market through its direct sales operation in France and its distribution partners in Italy, Spain Switzerland and Austria. It distributes its products through an exclusive relationship with Getz Bros. & Co. Inc. in Korea, Japan and the rest of Asia. Recently, the company entered into an exclusive distribution agreement with The Lifemed Group Inc. to distribute its products in Canada.
The company spent $0.54 million accounting to 85.7% of its net sales towards its research and development activities during the fiscal year 2006.
The company classifies its geographic markets into two regions namely, Sales U.S. and Sales Exports. The Sales U.S. accounted for 44.6% of the total revenues of the company for the fiscal year 2006, followed by Sales Exports (55.4%).
MAJOR PRODUCTS AND SERVICES
Sutura is a medical device company which develops innovative, minimally invasive vascular suturing devices to suture vascular structures during open surgery and catheter-based procedures. The company’s key products include the following:
Products:
F5 Superstitch
F8 and F6 Superstitch
Superstitch Gudewire
F12 and F18 SUperstitch
Superstitch ASD and Superstitch PFO
Kwiknot
Brands:
Sutura
Superstitch
Kwiknot
galegroup.com
